11th Annual Medical Device Strategic Pricing & Accounts Conference To Share Best Practices For Value Proposition Development

June 21, 2021

June 21, 2021 13:45:30
Date: June 22-24, 2021 Virtual Event The 11th Annual Medical Device Strategic Pricing & Accounts Conference is being held from June 22-24, 2021, at Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medtech industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes in delivering educational programming through its curated conferences and research-based events. The official sponsor of this conference is PROS, an AI-powered commerce platform offering personalized customer experience solutions to MedTech companies, in addition to networking sponsor Charles River and Associates, and bronze sponsor ZS Pharma. The 3-day virtual conference will witness keynote panel discussions, fireside chats, and group discussions where participants will get in-depth insights into the industry practices to regulate and control the pricing of the medical device landscape. The conference has 3 major modules distributed over three days and eminent MedTech industry veterans will facilitate and offer their invaluable opinions on the various topics outlined in the agenda of the conference. Some important topics and discussions covered in the Conference include:
  • Assessment of policy changes for the purchase and pricing of medical devices during the Biden administration
  • Developing a harmonious value proposition between the traditional practices as well as the evolving health care market
  • Roadblocks encountered due to the impact of the pandemic that has increased the need for virtual interactions
  • Growth of the Medtech sector during the pandemic
  • Use of AI for a better buying and selling experience of the consumer
  • Building a culture of ethics and compliance parameters that must be considered for contract negotiations
  • Discussions with GPOs, IDNs, and manufacturers, to prepare pricing and enterprise sales teams for upcoming healthcare challenges
  • Addressing the impact of outpatient center needs on hospital revenue generation and the impact on supplier & provider processes
  • Contemporary improvements to the Medtech pricing model
  • Impact on performance-based pricing due to COVID-19
The conference modules cover all aspects of medical device strategic pricing serving as a complete Medtech pricing learning guide for newbies and established companies in the medical device segment. For more details regarding the event, please visit https://ibn.fm/8X32c

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.